BRPI0514248A - compostos orgánicos - Google Patents

compostos orgánicos

Info

Publication number
BRPI0514248A
BRPI0514248A BRPI0514248-2A BRPI0514248A BRPI0514248A BR PI0514248 A BRPI0514248 A BR PI0514248A BR PI0514248 A BRPI0514248 A BR PI0514248A BR PI0514248 A BRPI0514248 A BR PI0514248A
Authority
BR
Brazil
Prior art keywords
compounds
organic compounds
inflammatory
condition
ccr
Prior art date
Application number
BRPI0514248-2A
Other languages
English (en)
Inventor
Darren Mark Legrand
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0514248A publication Critical patent/BRPI0514248A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPOSTOS ORGáNICOS. A presente invenção refere-se aos compostos de fórmula I na forma livre ou de sal, na qual Ar, X , Y e T têm os significados indicados no relatório, são úteis para o tratamento de uma condição mediada pelo CCR-3, particularmente uma condição inflamatória ou alérgica tal como uma doença inflamatória ou obstrutiva das vias aéreas. São também descritas as composições farmacêuticas que contêm os compostos e os processos de preparação dos compostos.
BRPI0514248-2A 2004-08-10 2005-08-09 compostos orgánicos BRPI0514248A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417801.8A GB0417801D0 (en) 2004-08-10 2004-08-10 Organic compounds
PCT/EP2005/008654 WO2006015854A2 (en) 2004-08-10 2005-08-09 Azetidine derivatives as ccr-3 receptor antagonists

Publications (1)

Publication Number Publication Date
BRPI0514248A true BRPI0514248A (pt) 2008-06-03

Family

ID=33017254

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514248-2A BRPI0514248A (pt) 2004-08-10 2005-08-09 compostos orgánicos

Country Status (17)

Country Link
US (1) US7691841B2 (pt)
EP (1) EP1781606B1 (pt)
JP (1) JP2008509185A (pt)
KR (1) KR20070045242A (pt)
CN (1) CN101175722B (pt)
AT (1) ATE438620T1 (pt)
AU (1) AU2005270308B2 (pt)
BR (1) BRPI0514248A (pt)
CA (1) CA2572748A1 (pt)
DE (1) DE602005015866D1 (pt)
ES (1) ES2330125T3 (pt)
GB (1) GB0417801D0 (pt)
MX (1) MX2007001646A (pt)
PL (1) PL1781606T3 (pt)
PT (1) PT1781606E (pt)
RU (1) RU2007108657A (pt)
WO (1) WO2006015854A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934265B1 (fr) * 2008-07-23 2010-07-30 Sanofi Aventis Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
NZ595431A (en) * 2009-04-16 2013-12-20 Janssen Pharmaceutica Nv 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
CA2758929A1 (en) * 2009-04-17 2010-10-21 Janssen Pharmaceutica Nv 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9609374D0 (en) 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
CA2378499A1 (en) * 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists
GB0117387D0 (en) * 2001-07-17 2001-09-05 Novartis Ag Organic compounds
JP2003155285A (ja) * 2001-11-19 2003-05-27 Toray Ind Inc 環状含窒素誘導体
AR041786A1 (es) 2002-03-15 2005-06-01 Novartis Ag Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento
WO2004050024A2 (en) * 2002-11-27 2004-06-17 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
DE60322423D1 (de) * 2002-12-13 2008-09-04 Smithkline Beecham Corp Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten
PL1663966T3 (pl) * 2003-09-15 2007-11-30 Novartis Ag 1,3-Dipodstawione pochodne azetydyny do zastosowania jako antagoniści receptora CCR-3 w leczeniu chorób zapalnych oraz alergicznych

Also Published As

Publication number Publication date
GB0417801D0 (en) 2004-09-15
EP1781606B1 (en) 2009-08-05
US7691841B2 (en) 2010-04-06
RU2007108657A (ru) 2008-09-20
KR20070045242A (ko) 2007-05-02
WO2006015854A2 (en) 2006-02-16
CN101175722B (zh) 2010-11-24
MX2007001646A (es) 2007-04-10
ES2330125T3 (es) 2009-12-04
ATE438620T1 (de) 2009-08-15
PT1781606E (pt) 2009-10-26
US20070259848A1 (en) 2007-11-08
DE602005015866D1 (de) 2009-09-17
CN101175722A (zh) 2008-05-07
WO2006015854A3 (en) 2007-08-30
CA2572748A1 (en) 2006-02-16
JP2008509185A (ja) 2008-03-27
AU2005270308B2 (en) 2009-10-22
EP1781606A2 (en) 2007-05-09
PL1781606T3 (pl) 2010-01-29
AU2005270308A1 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
EA201000123A1 (ru) Органические соединения
TW200628154A (en) Organic compounds
TN2010000167A1 (en) Organic compounds
PT1902037E (pt) 2,4-diamino-pirimidinas como inibidores de aurora
GB0305152D0 (en) Organic compounds
EA201001687A1 (ru) Производные имидазопиридина в качестве ингибиторов активиноподобной рецепторной киназы ( alk-4 или alk-5 )
EA201001126A1 (ru) Пирролопиримидины и пирролопиридины
EA201001455A1 (ru) Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3)
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
MA32811B1 (fr) Nouveaux composés
GEP20105074B (en) Pyrimidinyl aryl urea derivatives being fgf inhibitors
ATE454380T1 (de) Organische verbindungen zur behandlung entzündlicher oder allergischer leiden
EA201170520A1 (ru) Ингибитор p38 mapk-киназы
MA32505B1 (fr) 5-alcynyl-pyrimidines
TW200637863A (en) Organic compounds
TW200630374A (en) Thiazolyldihydroindazoles
GB0417910D0 (en) Organic compounds
TW200745066A (en) Novel PTP1B inhibitors
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
TW200630366A (en) Organic compounds
TW200800993A (en) Organic compounds
WO2007068473A3 (en) Organic compounds
GB0602951D0 (en) Organic Compounds
GB0417801D0 (en) Organic compounds
GB0417804D0 (en) Organic compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.